Analysis
Claros closed a $55 million Series B round to push its PFAS destruction technology toward broader commercial deployment. The company's core product, ClarosTechUV, is pitched as a permanent, on-site destruction method for PFAS -- so-called "forever chemicals" -- as opposed to the capture-and-landfill approach that most incumbent remediation providers still rely on, which merely relocates the contamination rather than eliminating it.
Alongside the destruction technology, Claros is expanding ClarosLabs, a mobile testing business that gives the company a diagnostic revenue line independent of the remediation product itself -- a structure that reduces reliance on any single sales cycle and lets Claros capture customers earlier, at the testing stage, before they commit to a remediation vendor.
The round reflects a broader shift in climate-adjacent venture capital toward remediation technology with defined, regulation-driven demand rather than pure decarbonization bets whose economics depend more heavily on carbon pricing or subsidy policy. PFAS liability has become an increasingly quantifiable risk for utilities, manufacturers and municipalities as EPA rules tighten and litigation exposure grows, giving companies like Claros a clearer near-term commercial runway than many climate-tech peers.
What to watch: Claros's first announced municipal or utility contracts at commercial scale, and how ClarosTechUV's cost-per-gallon compares with incumbent capture-based remediation as adoption widens.
